Abstract
Objective
Obstructive jaundice is frequently present in patients with advanced gastric carcinoma. The purpose of this study was to assess the cause and preferential site of bile duct obstruction in patients with gastric carcinoma and to evaluate correlativity of biliary obstruction with the nature of the primary gastric lesion.
Methods
Cholangiographic findings of 54 patients with metastatic gastric carcinoma presenting with obstructive jaundice were reviewed retrospectively.
The level of the bile duct obstruction was divided into four segments: segment 1, from an individual intrahepatic duct to the biliary hilum; segment 2, common hepatic duct (CHD) involvement from the biliary hilum to the level of the cystic duct; segment 3, the proximal half of the common bile duct (CBD); segment 4, the distal half of the CBD. To evaluate the characteristics of the primary gastric lesion, operative records and pathologic findings were reviewed.
Results
Obstruction sites were segment 1 in eight patients (15%), segment 2 in 25 (46%), segment 3 in 17 (32%), and segment 4 in four (7%). The causes of obstruction were metastatic lymphadenopathy in the hepatoduodenal ligament (50 of 54) and direct invasion of the primary or recurrent tumor (four of 54). The location of the primary gastric lesions was the antrum, antrum and body, and body in 36 (67%), 17 (31%), and 1 (2%), respectively. Borrmann type 3 lesions were present in 72% of cases, and type 2 lesions in the remaining 24%. Histologic type was undifferentiated adenocarcinoma in 91% of patients, and differentiated adenocarcinoma in the remaining. Serosal invasion was shown in 96% of the patients.
Conclusion
Our results show that the cause of bile duct obstruction in advanced gastric carcinoma is predominantly metastatic lymphadenopathy in the hepatoduodenal ligament, and its preferential site is around the level of the cystic duct. Obstructing lesions showed characteristic cholangiographic findings.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. Ann Surg 1989;210:596–602
Koga S, Kishimoto H, Tanaka K, Kawaguchi H. Clinical and pathologic evaluation of patients with recurrence of gastric cancer more than five years postoperatively. Am J Surg 1978;136:317–321
Wagner PK, Ramaswamy A, Ruschoff J, Schmitz-Moormann P, Rothmund M. Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer. Br J Surg 1991;78:825–827
Noguchi Y, Imada T, Matsumoto A, Coit DG, Brennan MF. Radical surgery for gastric cancer. Cancer 1989;64:2053–2062
Koga S, Takebayashi M, Kaibara N, et al. Pathological characteristics of gastric cancer that develop hematogenous recurrence, with special reference to the site of recurrence. J Surg Oncol 1987;36:239–242
Soga J, Ohyama S, Miyashita K, et al. A statistical evaluation of advancement gastric cancer surgery with special reference to the significance of lymphadenectomy for cure. World J Surg 1989;12:398–405
Japanese research society for gastric cancer. General rules for the gastric cancer study, 11th ed. Tokyo: Kanehara & Co. Ltd., 1985:4–29
Baron RL, Stanley RJ, Lee JKT, Koehler RE, Levitt RG. Computed tomographic features of biliary obstruction. AJR 1983;140:1173–1178
Honickman SP, Mueller PR, Wittenberg J, et al. Ultrasound in obstructive jaundice: prospective evaluation of site and cause. Radiology 1983;147:511–515
Lyttkens K, Forsberg L, Hederstrom E. Ultrasound examination of lymph nodes in the hepatoduodenal ligament. Br J Radiol 1990;63:26–30
Pedrosa CS, Casanova R, Rodriguez R. Computed tomography in obstructive jaundice. Radiology 1981;139:627–634
Pedrosa CS, Casanova R, Lezana AH, Fernandez MC. Computed tomography in obstructive jaundice. Radiology 1981;139:635–645
Gibson RN, Yeung E, Thompson JN, et al. Bile duct obstruction: radiologic evaluation of level, cause and tumor resectability. Radiology 1986;160:43–47
Borrmann R. Geschwulste des Magens. In: Henke FU, Lubarsch O, eds. Handbuch der speziellen patologischen anatomie und histologie. Berlin: Springer-Verlag, 1926:864–871
Ahn YO. Gastric cancer etiology and prevention. J Korean Med Assoc 1992;35:820–827
Ferrucci JT, Mueller PR, vanSonnenberg E. Transhepatic cholangiography. In: Berk RN, Ferrucci JT, Leopold GR, eds. Radiology of the gallbladder and bile ducts. Philadelphia: WB Saunders. 1983:347–350
Baker ME, Silverman PM, Halvorsen RA, Cohan RH. Computed tomography of masses in periportal/hepatoduodenal ligament. J Comput Assist Tomogr 1987;11:258–263
Yoshihiko M, Sunao M, Yoshihiro K, Shunji K, et al. Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery 1991;110:820–823
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, B.H., Chin, S.Y., Kim, S.A. et al. Obstructive jaundice in gastric carcinoma: cause, site, and relationship to the primary lesion. Abdom Imaging 20, 307–311 (1995). https://doi.org/10.1007/BF00203359
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00203359